BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10512760)

  • 1. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells.
    Estrera VT; Luo W; Phan D; Earley K; Hixson DC; Lin SH
    Biochem Biophys Res Commun; 1999 Oct; 263(3):797-803. PubMed ID: 10512760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains.
    Luo W; Wood CG; Earley K; Hung MC; Lin SH
    Oncogene; 1997 Apr; 14(14):1697-704. PubMed ID: 9135071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition.
    Luo W; Earley K; Tantingco V; Hixson DC; Liang TC; Lin SH
    Oncogene; 1998 Mar; 16(9):1141-7. PubMed ID: 9528856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
    Lin SH; Pu YS
    Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer model.
    Lin SH; Pu YS; Luo W; Wang Y; Logothetis CJ
    Anticancer Res; 1999; 19(1A):337-40. PubMed ID: 10226564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
    Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
    Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.
    Kleinerman DI; Dinney CP; Zhang WW; Lin SH; Van NT; Hsieh JT
    Cancer Res; 1996 Aug; 56(15):3431-5. PubMed ID: 8758907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-CAM1 expression: differential effects on morphology, differentiation state and suppression of human PC-3 prostate carcinoma cells.
    Comegys MM; Carreiro MP; Brown JF; Mazzacua A; Flanagan DL; Makarovskiy A; Lin SH; Hixson DC
    Oncogene; 1999 May; 18(21):3261-76. PubMed ID: 10359532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches.
    Hsieh JT; Luo W; Song W; Wang Y; Kleinerman DI; Van NT; Lin SH
    Cancer Res; 1995 Jan; 55(1):190-7. PubMed ID: 7805032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer.
    Hsieh JT; Earley K; Pong RC; Wang Y; Van NT; Lin SH
    Prostate; 1999 Sep; 41(1):31-8. PubMed ID: 10440873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of C-CAM1: effects of the cytoplasmic domain on cell aggregation.
    Lin SH; Luo W; Earley K; Cheung P; Hixson DC
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):239-45. PubMed ID: 7575460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
    Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
    Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.
    Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT
    Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and androgen regulation of C-CAM cell adhesion molecule isoforms in rat dorsal and ventral prostate.
    Makarovskiy AN; Pu YS; Lo P; Earley K; Paglia M; Hixson DC; Lin SH
    Oncogene; 1999 May; 18(21):3252-60. PubMed ID: 10359531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppressive activity of CD66a in prostate cancer.
    Luo W; Tapolsky M; Earley K; Wood CG; Wilson DR; Logothetis CJ; Lin SH
    Cancer Gene Ther; 1999; 6(4):313-21. PubMed ID: 10419049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470.
    Pu YS; Do KA; Luo W; Logothetis CJ; Lin SH
    Anticancer Drugs; 2002 Aug; 13(7):743-9. PubMed ID: 12187331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of human cell--cell adhesion molecule 1 (C-CAM1) expressed in insect cells.
    Phan D; Han E; Birrell G; Bonnal S; Duggan L; Esumi N; Gutstein H; Li R; Lopato S; Manogaran A; Pollak ES; Ray A; Reddi PP; Reichert AS; Struffi P; Tiscornia G; Ximenez-Fyvie LA; Zhang H; Lin SH
    Protein Expr Purif; 2001 Mar; 21(2):343-51. PubMed ID: 11237697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homophilic intercellular adhesion mediated by C-CAM is due to a domain 1-domain 1 reciprocal binding.
    Wikström K; Kjellström G; Obrink B
    Exp Cell Res; 1996 Sep; 227(2):360-6. PubMed ID: 8831574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth.
    Turbide C; Kunath T; Daniels E; Beauchemin N
    Cancer Res; 1997 Jul; 57(13):2781-8. PubMed ID: 9205090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.